Clinical utility of hereditary cancer panel testing: Impact of PALB2 , ATM , CHEK2 , NBN , BRIP1 , RAD51C , and RAD51D results on patient management and adherence to provider recommendations

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

(2018) Allison W. Kurian et al.   JAMA Oncology

Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings

(2018) Sandra Bonache et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non- BRCA cancer-associated genes

(2017) Melissa K. Frey et al.   GYNECOLOGIC ONCOLOGY

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative

(2017) Julia R. Trosman et al.   Journal of the National Comprehensive Cancer Network

Gene Panel Testing for Inherited Cancer Risk

(2017) Michael J. Hall et al.   Journal of the National Comprehensive Cancer Network

Counselling framework for moderate-penetrance cancer-susceptibility mutations

(2016) Nadine Tung et al.   Nature Reviews Clinical Oncology

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort

(2016) Charité Ricker et al.   Cancer Genetics

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

(2016) Marie Eliade et al.   Oncotarget

Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2

(2015) Lindsey E. Minion et al.   GYNECOLOGIC ONCOLOGY

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2015) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

(2015) Andrea Desmond et al.   JAMA Oncology

Multigene Panel Testing: Planning the Next Generation of Research Studies in Clinical Cancer Genetics

(2014) Mark Robson   JOURNAL OF CLINICAL ONCOLOGY

Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?

(2013) Susan M. Domchek et al.   JOURNAL OF CLINICAL ONCOLOGY

Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers

(2011) S. U. Dhar et al.   BREAST CANCER RESEARCH AND TREATMENT